• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
    • Green biotechnology
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
  • Team
    • Team
    • Collaborations
  • Insights
  • Work
    • Publications
    • Cases
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
    • Green biotechnology
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
  • Team
    • Team
    • Collaborations
  • Insights
  • Work
    • Publications
    • Cases
  • Careers
  • Contact
  • You are here:
  • Home
  • Team
  • Dr. Monica Autiero

Dr. Monica Autiero

Dr. Monica Autiero is a Senior Consultant at ToxMinds BVBA and leads ToxMinds’ efforts in the area of non-animal based safety assessments with particular focus on (Q)SAR modelling and identifying analogue and read across-based hazard assessment approaches. She has significant project experience in using in silico tools under various EU regulatory frameworks, particularly with regard to developing read-across justification in line with ECHA’s Read Across Assessment Framework (RAAF) under REACH or the SCCS guidance for the safety evaluation of cosmetic ingredients.

Before joining ToxMinds in 2013, she worked for many years in various positions in academia at the University in Leuven and as project manager in GlaxoSmithKline. Monica is a trained biologist with a Ph.D. in Biochemistry and Molecular Biology from the University Paris XI, France.

Languages: EN, IT, FR

Contact

Dr. Monica Autiero
Senior Consultant

Phone: +32 (0)2 762 91 45
Email: contact me

Specialities

Chemicals, Cosmetics, Pharma, Green biotechnology

REACH, QSAR & PPBK modelling, Analogue identification & read-across justification

INSIGHTS & PUBLICATIONS
  • Mutagenicity assessment of drug impurities according to the ICH M7 (R1) guideline and the role of expert review

  • Read-across – State of the art and next level!

  • Reducing uncertainty in read across based chemical safety assessments. Mishra S, Autiero M, Balteau M, Tencalla F, Petry T. Toxicology Letters 2016, 258:S314.

Dr. Francesca Tencalla

Previous thumb

Dr. Julie Muller

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BVBA
Avenue de Broqueville 116
B-1200 Brussels, Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
1015 Brigade IRV Centre, 10th Floor
Whitefield, Bangalore 560066, India

 

Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Work
  • Careers
  • Contact